Filing Details
- Accession Number:
- 0001104659-22-077306
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-07-05 16:06:04
- Reporting Period:
- 2022-06-30
- Accepted Time:
- 2022-07-05 16:06:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1297184 | Amphastar Pharmaceuticals Inc. | AMPH | Pharmaceutical Preparations (2834) | 330702205 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1611283 | G. Diane Gerst | C/O Amphastar Pharmaceuticals, Inc. 11570 6Th Street Rancho Cucamonga CA 91730 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-06-30 | 3,333 | $20.03 | 16,175 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2022-06-30 | 1,813 | $20.08 | 17,988 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-06-30 | 5,146 | $35.00 | 12,842 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2022-06-30 | 3,333 | $0.00 | 3,333 | $20.03 |
| Common Stock | Stock Option (right to buy) | Disposition | 2022-06-30 | 1,813 | $0.00 | 1,813 | $20.08 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 3,626 | 2027-06-12 | No | 4 | M | Direct | |
| 6,190 | 2028-06-08 | No | 4 | M | Direct |
Footnotes
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2022.
- Shares subject to the option are fully vested and immediately exercisable.
Billionaire Hedge Funds
